tradingkey.logo

Concentra Group Holdings Parent Inc

CON
19.630USD
+0.110+0.56%
Cierre 12/18, 16:00ETCotizaciones retrasadas 15 min
2.52BCap. mercado
13.19P/E TTM

Concentra Group Holdings Parent Inc

19.630
+0.110+0.56%

Más Datos de Concentra Group Holdings Parent Inc Compañía

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. It delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day, on average, from about 620 occupational health centers in 41 states and 160 onsite health clinics at employer worksites in 36 states. Its Occupational Health Centers segment encompasses the services it delivers at its occupational health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment comprises several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.

Información de Concentra Group Holdings Parent Inc

Símbolo de cotizaciónCON
Nombre de la empresaConcentra Group Holdings Parent Inc
Fecha de salida a bolsaJul 25, 2024
Director ejecutivoNewton (William Keith)
Número de empleados8758
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 25
Dirección5080 Spectrum Drive
CiudadADDISON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal75001
Teléfono19723648000
Sitio Web
Símbolo de cotizaciónCON
Fecha de salida a bolsaJul 25, 2024
Director ejecutivoNewton (William Keith)

Ejecutivos de Concentra Group Holdings Parent Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Chairman of the Board
Chairman of the Board
8.17M
-0.96%
Mr. William Keith Newton
Mr. William Keith Newton
Chief Executive Officer, Director
Chief Executive Officer, Director
482.83K
+87.27%
Mr. Thomas Devasia
Mr. Thomas Devasia
Executive Vice President, Chief Marketing and Innovation Officer
Executive Vice President, Chief Marketing and Innovation Officer
114.10K
+90.16%
Mr. Giovanni Gallara
Mr. Giovanni Gallara
Executive Vice President, Chief Clinical Services Officer
Executive Vice President, Chief Clinical Services Officer
113.44K
+89.06%
Ms. Danielle Kendall
Ms. Danielle Kendall
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
76.06K
+90.16%
Dr. John R. Anderson
Dr. John R. Anderson
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Dr. Marc R. Watkins, M.D.
Dr. Marc R. Watkins, M.D.
Independent Director
Independent Director
--
--
Ms. Su Zan Nelson, CPA
Ms. Su Zan Nelson, CPA
Executive Vice President, Chief Accounting Officer
Executive Vice President, Chief Accounting Officer
--
--
Mr. Douglas R. Mcandrew
Mr. Douglas R. Mcandrew
Executive Vice President, Chief Operating Officer - West
Executive Vice President, Chief Operating Officer - West
--
--
Mr. Michael A. Kosuth
Mr. Michael A. Kosuth
Executive Vice President, Chief Operating Officer - East
Executive Vice President, Chief Operating Officer - East
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Chairman of the Board
Chairman of the Board
8.17M
-0.96%
Mr. William Keith Newton
Mr. William Keith Newton
Chief Executive Officer, Director
Chief Executive Officer, Director
482.83K
+87.27%
Mr. Thomas Devasia
Mr. Thomas Devasia
Executive Vice President, Chief Marketing and Innovation Officer
Executive Vice President, Chief Marketing and Innovation Officer
114.10K
+90.16%
Mr. Giovanni Gallara
Mr. Giovanni Gallara
Executive Vice President, Chief Clinical Services Officer
Executive Vice President, Chief Clinical Services Officer
113.44K
+89.06%
Ms. Danielle Kendall
Ms. Danielle Kendall
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
76.06K
+90.16%
Dr. John R. Anderson
Dr. John R. Anderson
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Occupational health centers - Workers compensation
332.19M
60.31%
Occupational health centers - Employer services
174.32M
31.65%
Onsite clinics
22.57M
4.10%
Other
12.08M
2.19%
Occupational health centers - Consumer health
7.18M
1.30%
Other occupational health center revenue
2.45M
0.45%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Occupational health centers - Workers compensation
332.19M
60.31%
Occupational health centers - Employer services
174.32M
31.65%
Onsite clinics
22.57M
4.10%
Other
12.08M
2.19%
Occupational health centers - Consumer health
7.18M
1.30%
Other occupational health center revenue
2.45M
0.45%

Estadísticas de accionistas

Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
T. Rowe Price Associates, Inc.
13.28%
BlackRock Institutional Trust Company, N.A.
12.38%
The Vanguard Group, Inc.
10.28%
Ortenzio (Robert A)
6.37%
T. Rowe Price Investment Management, Inc.
4.88%
Otro
52.81%
Accionistas
Accionistas
Proporción
T. Rowe Price Associates, Inc.
13.28%
BlackRock Institutional Trust Company, N.A.
12.38%
The Vanguard Group, Inc.
10.28%
Ortenzio (Robert A)
6.37%
T. Rowe Price Investment Management, Inc.
4.88%
Otro
52.81%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
59.75%
Investment Advisor/Hedge Fund
18.12%
Individual Investor
10.71%
Hedge Fund
6.66%
Research Firm
2.49%
Sovereign Wealth Fund
1.21%
Pension Fund
1.17%
Bank and Trust
0.75%
Insurance Company
0.03%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
468
115.54M
92.17%
+1.31K
2025Q3
468
115.54M
92.15%
+6.14M
2025Q2
437
109.05M
87.68%
-456.06K
2025Q1
406
109.58M
85.04%
+578.97K
2024Q4
355
109.93M
36.49%
+63.12M
2024Q3
113
28.34M
4.83%
+22.18M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
T. Rowe Price Associates, Inc.
13.76M
10.74%
-827.64K
-5.67%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
15.27M
11.92%
-10.34K
-0.07%
Jun 30, 2025
The Vanguard Group, Inc.
13.15M
10.26%
+1.05M
+8.65%
Jun 30, 2025
Ortenzio (Robert A)
8.25M
6.43%
+1.01M
+13.96%
Mar 03, 2025
T. Rowe Price Investment Management, Inc.
7.66M
5.98%
+108.33K
+1.43%
Jun 30, 2025
State Street Investment Management (US)
4.27M
3.33%
+52.88K
+1.25%
Jun 30, 2025
Rocco A. Ortenzio UEO
3.30M
2.57%
-3.07M
-48.22%
Mar 03, 2025
Thrivent Asset Management, LLC
2.30M
1.79%
-210.45K
-8.38%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
3.20M
2.5%
-54.90K
-1.69%
Jun 30, 2025
JP Morgan Asset Management
2.67M
2.08%
+135.19K
+5.33%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Texas Capital Texas Small Cap Equity Index ETF
2.5%
State Street SPDR S&P Health Care Services ETF
1.88%
Invesco S&P SmallCap Health Care ETF
1.45%
Harbor Human Capital Factor US Small Cap ETF
0.8%
JPMorgan Active Small Cap Value ETF
0.79%
Texas Capital Texas Equity Index ETF
0.62%
Invesco S&P SmallCap Quality ETF
0.54%
JPMorgan Fundamental Data Science Small Core ETF
0.51%
T Rowe Price Small-Mid Cap ETF
0.45%
iShares U.S. Healthcare Providers ETF
0.37%
Ver más
Texas Capital Texas Small Cap Equity Index ETF
Proporción2.5%
State Street SPDR S&P Health Care Services ETF
Proporción1.88%
Invesco S&P SmallCap Health Care ETF
Proporción1.45%
Harbor Human Capital Factor US Small Cap ETF
Proporción0.8%
JPMorgan Active Small Cap Value ETF
Proporción0.79%
Texas Capital Texas Equity Index ETF
Proporción0.62%
Invesco S&P SmallCap Quality ETF
Proporción0.54%
JPMorgan Fundamental Data Science Small Core ETF
Proporción0.51%
T Rowe Price Small-Mid Cap ETF
Proporción0.45%
iShares U.S. Healthcare Providers ETF
Proporción0.37%

Dividendos

Un total de 7.96M USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 06, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Dec 09, 2025 going ex on Dec 02, 2025
Dec 02, 2025
Dec 09, 2025
Dec 02, 2025
Aug 07, 2025
CON.NB Final Cash Dividend of gross USD 0.0625 paid on Aug 28, 2025 going ex on Aug 21, 2025
Aug 21, 2025
Aug 28, 2025
Aug 21, 2025
May 07, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on May 29, 2025 going ex on May 20, 2025
May 20, 2025
May 29, 2025
May 20, 2025
Feb 28, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Apr 01, 2025 going ex on Mar 18, 2025
Mar 18, 2025
Apr 01, 2025
Mar 18, 2025
Oct 31, 2024
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Nov 22, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 22, 2024
Nov 13, 2024

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Concentra Group Holdings Parent Inc?

Los cinco principales accionistas de Concentra Group Holdings Parent Inc son:
T. Rowe Price Associates, Inc. posee 13.76M acciones, lo que representa el 10.74% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 15.27M acciones, lo que representa el 11.92% del total de acciones.
The Vanguard Group, Inc. posee 13.15M acciones, lo que representa el 10.26% del total de acciones.
Ortenzio (Robert A) posee 8.25M acciones, lo que representa el 6.43% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 7.66M acciones, lo que representa el 5.98% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Concentra Group Holdings Parent Inc?

Los tres principales tipos de accionista de Concentra Group Holdings Parent Inc son:
T. Rowe Price Associates, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

¿Cuántas instituciones poseen acciones de Concentra Group Holdings Parent Inc (CON)?

A fecha de 2025Q4, 468 instituciones poseen acciones de Concentra Group Holdings Parent Inc, con un valor de mercado combinado de aproximadamente 115.54M, lo que representa el 92.17% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en 0.02%.

¿Cuál es la mayor fuente de ganancias de Concentra Group Holdings Parent Inc?

El FY2025Q2, el segmento empresarial Occupational health centers - Workers compensation generó la ganancia más alta para Concentra Group Holdings Parent Inc, ascendiendo a 332.19M y representando el 60.31% de la ganancia total.
KeyAI